Evaluation of the Repeated Usage of Systane Ultra Eyedrop

Alcon

Status and phase

Completed

Phase 4

Conditions

Dry Eye

Treatments

Other: Optive lubricant Eye Drops

Other: Systane Ultra

Study type

Interventional

Funder types

Industry

Identifiers

SMA-09-33

Details and patient eligibility

About

Comparison of two contact lens solutions.

Enrollment

57 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 18 years or more.
Non contact lens wearer.
Symptomatology as defined below for the Ocular Surface Disease Index (OSDI) questionnaire:
- Score ≥13 for OSDI Questionnaire total score; AND
- Scores of at least 2 for 2 out of the 6 vision related questions of the OSDI questionnaire
Best visual acuity of 6/9 or better in each eye.
Willingness to adhere to the instructions set in the clinical protocol.
Signature of the subject informed consent form.

Exclusion criteria

Use of systemic medication which might produce dry eye side effects.
Systemic disease which might produce dry eye side effects.
Active ocular infection.
Use of ocular medication.
Significant ocular anomaly.
Previous ocular surgery
Previous use of Restasis
Any medical condition that might be prejudicial to the study.
The subject, based on their knowledge, must NOT be pregnant or lactating at the time of enrolment.
The subject, based on his/her knowledge, must NOT have an infectious disease (e.g. hepatitis, tuberculosis) or an immunosuppressive disease (e.g. Human Immunodeficiency Virus).
The subject, based on their knowledge, must NOT have diabetes.